WHWK Insider Trading Activity and SEC Form 4 Filings
WHWK insider trading summary
Over the past 12 months, insiders at Whitehawk Therapeutics, Inc. (WHWK) reported 11 sales worth $2.6M by 3 insiders and no open-market purchases on SEC Form 4. Net insider selling was $2.6M.
Latest WHWK insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 16, 2026 | Scott M. Giacobello | Chief Financial Officer | Sell | $585K (141,600 @ $4.13) |
| Apr 15, 2026 | Scott M. Giacobello | Chief Financial Officer | Sell | $297K (77,000 @ $3.86) |
| Apr 14, 2026 | Bryan Ball | See remarks | Sell | $337K (92,460 @ $3.64) |
| Apr 13, 2026 | Bryan Ball | See remarks | Sell | $91K (26,389 @ $3.46) |
| Apr 10, 2026 | Bryan Ball | See remarks | Sell | $23K (6,596 @ $3.43) |
| Apr 9, 2026 | Bryan Ball | See remarks | Sell | $179K (50,000 @ $3.57) |
| Apr 9, 2026 | David James Lennon | Chief Executive Officer | Sell | $49K (14,500 @ $3.38) |
| Apr 8, 2026 | David James Lennon | Chief Executive Officer | Sell | $217K (63,945 @ $3.40) |
| Apr 7, 2026 | David James Lennon | Chief Executive Officer | Sell | $323K (94,087 @ $3.43) |
| Apr 6, 2026 | David James Lennon | Chief Executive Officer | Sell | $359K (102,395 @ $3.51) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.